79 related articles for article (PubMed ID: 21879768)
1. Serum levels of pregnancy zone protein are elevated in presymptomatic Alzheimer's disease.
Ijsselstijn L; Dekker LJ; Stingl C; van der Weiden MM; Hofman A; Kros JM; Koudstaal PJ; Sillevis Smitt PA; Ikram MA; Breteler MM; Luider TM
J Proteome Res; 2011 Nov; 10(11):4902-10. PubMed ID: 21879768
[TBL] [Abstract][Full Text] [Related]
2. Serum clusterin levels are not increased in presymptomatic Alzheimer's disease.
IJsselstijn L; Dekker LJ; Koudstaal PJ; Hofman A; Sillevis Smitt PA; Breteler MM; Luider TM
J Proteome Res; 2011 Apr; 10(4):2006-10. PubMed ID: 21280673
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy Zone Protein is Increased in the Alzheimer's Disease Brain and Associates with Senile Plaques.
Nijholt DA; Ijsselstijn L; van der Weiden MM; Zheng PP; Sillevis Smitt PA; Koudstaal PJ; Luider TM; Kros JM
J Alzheimers Dis; 2015; 46(1):227-38. PubMed ID: 25737043
[TBL] [Abstract][Full Text] [Related]
4. Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker.
Khan TK; Alkon DL
Neurobiol Aging; 2010 Jun; 31(6):889-900. PubMed ID: 18760507
[TBL] [Abstract][Full Text] [Related]
5. Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease.
Güntert A; Campbell J; Saleem M; O'Brien DP; Thompson AJ; Byers HL; Ward MA; Lovestone S
J Alzheimers Dis; 2010; 21(2):585-96. PubMed ID: 20571216
[TBL] [Abstract][Full Text] [Related]
6. The influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levels.
Abdullah L; Paris D; Luis C; Quadros A; Parrish J; Valdes L; Keegan AP; Mathura V; Crawford F; Mullan M
Neurosci Lett; 2007 Nov; 428(2-3):53-8. PubMed ID: 17964720
[TBL] [Abstract][Full Text] [Related]
7. C4b-binding protein in Alzheimer's disease: binding to Abeta1-42 and to dead cells.
Trouw LA; Nielsen HM; Minthon L; Londos E; Landberg G; Veerhuis R; Janciauskiene S; Blom AM
Mol Immunol; 2008 Aug; 45(13):3649-60. PubMed ID: 18556068
[TBL] [Abstract][Full Text] [Related]
8. A novel blood test for the early detection of Alzheimer's disease.
Rye PD; Booij BB; Grave G; Lindahl T; Kristiansen L; Andersen HM; Horndalsveen PO; Nygaard HA; Naik M; Hoprekstad D; Wetterberg P; Nilsson C; Aarsland D; Sharma P; Lönneborg A
J Alzheimers Dis; 2011; 23(1):121-9. PubMed ID: 20930265
[TBL] [Abstract][Full Text] [Related]
9. Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study.
Sundelöf J; Kilander L; Helmersson J; Larsson A; Rönnemaa E; Degerman-Gunnarsson M; Sjögren P; Basun H; Lannfelt L; Basu S
J Alzheimers Dis; 2009; 18(1):71-8. PubMed ID: 19542632
[TBL] [Abstract][Full Text] [Related]
10. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B
Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248
[TBL] [Abstract][Full Text] [Related]
11. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.
Tully AM; Roche HM; Doyle R; Fallon C; Bruce I; Lawlor B; Coakley D; Gibney MJ
Br J Nutr; 2003 Apr; 89(4):483-9. PubMed ID: 12654166
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K
Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992
[TBL] [Abstract][Full Text] [Related]
13. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease.
Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M
Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718
[TBL] [Abstract][Full Text] [Related]
14. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
von Rotz RC; Kins S; Hipfel R; von der Kammer H; Nitsch RM
Eur J Neurosci; 2005 Mar; 21(5):1289-98. PubMed ID: 15813938
[TBL] [Abstract][Full Text] [Related]
15. Serum proteome analyzed to reveal increased levels of PZP in Alzheimer's patients.
Lake F
Expert Rev Proteomics; 2011 Dec; 8(6):686. PubMed ID: 22195313
[No Abstract] [Full Text] [Related]
16. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
[TBL] [Abstract][Full Text] [Related]
17. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
[TBL] [Abstract][Full Text] [Related]
18. Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study.
Sundelöf J; Kilander L; Helmersson J; Larsson A; Rönnemaa E; Degerman-Gunnarsson M; Basun H; Lannfelt L; Basu S
J Alzheimers Dis; 2009; 18(1):79-87. PubMed ID: 19542629
[TBL] [Abstract][Full Text] [Related]
19. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH
Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
[TBL] [Abstract][Full Text] [Related]
20. Delayed rather than decreased BOLD response as a marker for early Alzheimer's disease.
Rombouts SA; Goekoop R; Stam CJ; Barkhof F; Scheltens P
Neuroimage; 2005 Jul; 26(4):1078-85. PubMed ID: 15961047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
